For Li, a former Roche scientist, Hua's partnership deal brings the advantages of a tie-up with a global industry leader to a company with a staff of around just 25 people, which he founded himself in Shanghai five years ago. "We were looking for ...
Hua has a deal in place to develop drugs including a diabetes treatment licenced from Swiss giant Roche Holding AG. While firms like Hua can help global drugmakers navigate complex regulatory risks, speeding up approvals in treatment areas like ...
Hua has a deal in place to develop drugs including a diabetes treatment licenced from Swiss giant Roche Holding AG. While firms like Hua can help global drugmakers navigate complex regulatory risks, speeding up approvals in treatment areas like ...
Hua has a deal in place to develop drugs including a diabetes treatment licenced from Swiss giant Roche Holding AG. While firms like Hua can help global drugmakers navigate complex regulatory risks, speeding up approvals in treatment areas like ...
For Li, a former Roche scientist, Hua's partnership deal brings the advantages of a tie-up with a global industry leader to a company with a staff of around just 25 people, which he founded himself in Shanghai five years ago. "We were looking for ...
Hua has a deal in place to develop drugs including a diabetes treatment licenced from Swiss giant Roche Holding AG. While firms like Hua can help global drugmakers navigate complex regulatory risks, speeding up approvals in treatment areas like ...